Sandeep Laumas Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sandeep Laumas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sandeep Laumas. Sandeep Laumas is CEO, Executive Chairman in INNOVATE BIOPHARMACEUTICALS, INC. ($INNT) and Director in INNOVATE BIOPHARMACEUTICALS, INC. ($INNT) and Executive Chairman in INNOVATE BIOPHARMACEUTICALS, INC. ($INNT) and Director in BioXcel Therapeutics, Inc. ($BTAI) and CFO and CBO in Instil Bio, Inc. ($TIL).
Latest Insider Trading Transactions of Sandeep Laumas
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, INNT, BTAI, TIL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | TIL | Instil Bio, Inc. | Laumas Sandeep | CFO and CBO | Option Exercise | A | 16.25 | 200,000 | 3,250,000 | 200,000 | |
| May 13 2021 | TIL | Instil Bio, Inc. | Laumas Sandeep | CFO and CBO | Option Exercise | A | 16.25 | 200,000 | 3,250,000 | 200,000 | |
| Mar 22 2021 | TIL | Instil Bio, Inc. | Laumas Sandeep | CFO and CBO | Option Exercise | A | 5.95 | 240,000 | 1,428,000 | 240,000 | |
| Jul 08 2020 | INNT | 9 METERS BIOPHARMA ... | Laumas Sandeep | Director | Option Exercise | A | 0.62 | 150,000 | 93,240 | 150,000 | |
| Jul 02 2020 | INNT | 9 METERS BIOPHARMA ... | Laumas Sandeep | Director | Option Exercise | C | 0.00 | 424 | 0 | 0 | |
| Jul 02 2020 | INNT | 9 METERS BIOPHARMA ... | Laumas Sandeep | Director | Buy | C | 0.00 | 42,400 | 0 | 60,400 | 18 K to 60.4 K (+235.56 %) |
| May 26 2020 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
| May 04 2020 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Director | Option Exercise | P | 0.00 | 424 | 0 | 42,400 | |
| May 04 2020 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Director | Option Exercise | P | 0.00 | 424 | 0 | 42,400 | |
| May 04 2020 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Director | Option Exercise | A | 0.60 | 389,294 | 233,576 | 389,294 | |
| Aug 27 2019 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | CEO, Executive Chai ... | Option Exercise | A | 0.89 | 400,000 | 356,000 | 400,000 | |
| Jul 01 2019 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | CEO, Executive Chai ... | Buy | P | 1.15 | 4,000 | 4,600 | 18,000 | 14 K to 18 K (+28.57 %) |
| Jun 17 2019 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | CEO, Executive Chai ... | Buy | P | 1.22 | 591 | 721 | 14,000 | 13.4 K to 14 K (+4.41 %) |
| Jun 17 2019 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | CEO, Executive Chai ... | Buy | P | 1.21 | 409 | 495 | 13,409 | 13 K to 13.4 K (+3.15 %) |
| May 28 2019 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 10.04 | 14,700 | 147,588 | 14,700 | |
| May 23 2019 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | CEO, Executive Chai ... | Buy | P | 1.38 | 5,000 | 6,900 | 13,000 | 8 K to 13 K (+62.50 %) |
| Dec 03 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 2.63 | 1,000 | 2,630 | 8,000 | 7 K to 8 K (+14.29 %) |
| Dec 03 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 2.62 | 1,000 | 2,620 | 7,000 | 6 K to 7 K (+16.67 %) |
| Dec 03 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 2.64 | 1,000 | 2,640 | 6,000 | 5 K to 6 K (+20.00 %) |
| Nov 29 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 2.56 | 2,000 | 5,120 | 5,000 | 3 K to 5 K (+66.67 %) |
| Nov 29 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 2.55 | 1,000 | 2,550 | 3,000 | 2 K to 3 K (+50.00 %) |
| Sep 10 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 6.10 | 500 | 3,050 | 2,000 | 1.5 K to 2 K (+33.33 %) |
| Aug 30 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 5.24 | 500 | 2,620 | 750 | 250 to 750 (+200.00 %) |
| Aug 28 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 5.08 | 405 | 2,057 | 1,000 | 595 to 1,000 (+68.07 %) |
| Aug 28 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 5.07 | 95 | 482 | 595 | 500 to 595 (+19.00 %) |
| Aug 28 2018 | INNT | INNOVATE BIOPHARMA ... | Laumas Sandeep | Executive Chairman | Buy | P | 4.88 | 250 | 1,220 | 500 | 250 to 500 (+100.00 %) |
| Mar 13 2018 | BTAI | BioXcel Therapeuti ... | Laumas Sandeep | Director | Option Exercise | A | 11.00 | 37,209 | 409,299 | 124,188 |
Page: 1